menu
    • menu

    Company profile for BioXcel Therapeutics

    NEW Drugs in Dev: 5
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology. We are focused on utilizing cutting-edge technology & innovative research to develop high value therapeutics aimed at transforming patients’ lives. BioXcel Therapeutics employs a unique AI platform an effort to reduce thera...
    BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology. We are focused on utilizing cutting-edge technology & innovative research to develop high value therapeutics aimed at transforming patients’ lives. BioXcel Therapeutics employs a unique AI platform an effort to reduce therapeutic development costs and potentially accelerate timelines, while aiming to increase the possibility of success.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioXcel TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    555 Long Wharf Drive 12th Floor New Haven, CT 06511
    Telephone
    Telephone
    475-238-6837
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bioxceltherapeutics.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/bioxcel-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BioXcel_Tx?ref

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioXcel Therapeutics Announces IGALMI Launch Event
    BioXcel Therapeutics Announces IGALMI Launch Event

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187518

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    BioXcel Gets FDA Acceptance for IGALMI At-Home Use sNDA
    BioXcel Gets FDA Acceptance for IGALMI At-Home Use sNDA

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266468/0/en/BioXcel-Therapeutics-Announces-Food-Drug-Administration-Acceptance-of-Supplemental-New-Drug-Application-for-Use-of-IGALMI-in-the-At-Home-Setting.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    BioXcel Therapeutics Reports Fourth Quarter and Financial Results
    BioXcel Therapeutics Reports Fourth Quarter and Financial Results

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263683/0/en/BioXcel-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-as-Company-Prepares-for-Potential-IGALMI-Approval-in-Outpatient-Setting.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Bioxcel Therapeutics Closes $8M Direct Offering
    Bioxcel Therapeutics Closes $8M Direct Offering

    11 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3254158/0/en/BioXcel-Therapeutics-Announces-Closing-of-8-0-Million-Registered-Direct-Offering.html

    GLOBENEWSWIRE
    11 Mar 2026
    Share Share
    Bioxcel Therapeutics Reveals $8M Registered Direct Offering
    Bioxcel Therapeutics Reveals $8M Registered Direct Offering

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3253239/0/en/BioXcel-Therapeutics-Announces-Approximately-8-0-Million-Registered-Direct-Offering.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Bioxcel Therapeutics Reports Positive Phase 2 Results
    Bioxcel Therapeutics Reports Positive Phase 2 Results

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250004/0/en/BioXcel-Therapeutics-Announces-Positive-Phase-2-Topline-Results-from-Columbia-University-Led-Study-of-BXCL501-for-Treatment-of-Opioid-Withdrawal.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search